Question 1

Does BlackRock own CLYM stock?

Accepted Answer

Yes. As of its Q2 2026 13F, BlackRock holds 2,354,872 shares of CLYM (Climb Bio), worth $30.7M.

Question 2

How many shares of CLYM does BlackRock own?

Accepted Answer

As of its Q2 2026 13F, BlackRock holds 2,354,872 shares of CLYM (Climb Bio).

Question 3

What is BlackRock's CLYM position worth?

Accepted Answer

As of its Q2 2026 13F, BlackRock's CLYM position is worth $30.7M.

Question 4

Is BlackRock buying or selling CLYM?

Accepted Answer

In Q2 2026, BlackRock increased its CLYM position from 401,649 to 2,354,872 shares.

Question 5

When did BlackRock first buy CLYM?

Accepted Answer

BlackRock already held CLYM in its Q3 2024 13F, the earliest on record, and has listed it in 8 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	2.4M	+486.3%	$30.7M	0.0%	$13.04	47
2026-Q1	Increased	401,649	+3.2%	$2.8M	0.0%	$6.85	18
2025-Q4	Decreased	389,309	-47.1%	$1.6M	0.0%	$4.00	0
2025-Q3	Decreased	735,503	-16.2%	$1.5M	0.0%	$2.01	0
2025-Q2	Decreased	877,969	-61.8%	$1.1M	0.0%	$1.24	0
2025-Q1	Decreased	2.3M	-0.4%	$2.8M	0.0%	$1.22	0
2024-Q4	Increased	2.3M	+23.5%	$4.2M	0.0%	$1.80	32
2024-Q3	First report	1.9M	-	$9.5M	0.0%	$5.09	0

CLYM8 quarters

CLYM
8 quarters